LyP-1 conjugated nanoparticles for magnetic resonance imaging of triple negative breast cancer

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.1007/s11307-017-1140-4
AuthorSearch for: 1 ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for:
Name affiliation
  1. National Research Council Canada. Human Health Therapeutics
FormatText
TypeArticle
Journal titleMolecular Imaging and Biology
ISSN1536-1632
1860-2002
Pages# of pages: 8
Subjectbreast cancer; triple negative; MRI; optical imaging; LyP1 peptide; iron oxide nanoparticles; molecular imaging
Abstract
Publication date
PublisherSpringer
NoteCorrection to: LyP-1 Conjugated Nanoparticles for Magnetic Resonance Imaging of Triple Negative Breast Cancer (Molecular Imaging and Biology, (2018), 20, 3, (428-435), 10.1007/s11307-017-1140-4)
LanguageEnglish
Peer reviewedYes
NPARC number23002408
Export citationExport as RIS
Report a correctionReport a correction
Record identifierb815ac89-5ce5-4802-a507-d5495ca2bfb1
Record created2017-11-06
Record modified2018-07-19
Date modified: